These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

687 related items for PubMed ID: 17457794

  • 41. Adverse drug reactions of antidepressants and antipsychotics: experience, knowledge and attitudes among Norwegian psychiatrists.
    Castberg I, Reimers A, Sandvik P, Aamo TO, Spigset O.
    Nord J Psychiatry; 2006; 60(3):227-33. PubMed ID: 16720514
    [Abstract] [Full Text] [Related]

  • 42. Adverse drug reactions and off-label prescribing for paediatric outpatients: a one-year survey of spontaneous reports in Sweden.
    Ufer M, Kimland E, Bergman U.
    Pharmacoepidemiol Drug Saf; 2004 Mar; 13(3):147-52. PubMed ID: 15072113
    [Abstract] [Full Text] [Related]

  • 43. Analysis of adverse drug reactions using drug and drug target interactions and graph-based methods.
    Lin SF, Xiao KT, Huang YT, Chiu CC, Soo VW.
    Artif Intell Med; 2010 Mar; 48(2-3):161-6. PubMed ID: 19962282
    [Abstract] [Full Text] [Related]

  • 44. Comparative study of prospective surveillance and voluntary reporting in determining the incidence of adverse drug reactions.
    Bennett BS, Lipman AG.
    Am J Hosp Pharm; 1977 Sep; 34(9):931-6. PubMed ID: 906995
    [Abstract] [Full Text] [Related]

  • 45. Adverse drug reactions among inpatients in a north Indian referral hospital.
    Uppal R, Jhaj R, Malhotra S.
    Natl Med J India; 2000 Sep; 13(1):16-8. PubMed ID: 10743370
    [Abstract] [Full Text] [Related]

  • 46. Spontaneously reported fatal suspected adverse drug reactions: a 10-year survey from Sweden.
    Wester K, Jönsson A, Spigset O, Hägg S.
    Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):173-80. PubMed ID: 16739241
    [Abstract] [Full Text] [Related]

  • 47. [Adverse events related to substitution of generic products in Norway 2005].
    Reppe LA, Stenberg-Nilsen H, Harg P, Hegge AB, Lillefloth AK, Buajordet I.
    Tidsskr Nor Laegeforen; 2008 Dec 04; 128(23):2696-700. PubMed ID: 19079413
    [Abstract] [Full Text] [Related]

  • 48. Pharmacy-coordinated program that encourages physician reporting of adverse drug reactions.
    Gilroy GW, Scollins MJ, Gay CA, Harry DJ, Giannuzzi DF.
    Am J Hosp Pharm; 1990 Jun 04; 47(6):1327-33. PubMed ID: 2368726
    [Abstract] [Full Text] [Related]

  • 49. Using a capture-recapture method to assess the frequency of adverse drug reactions in a French university hospital.
    Lugardon S, Desboeuf K, Fernet P, Montastruc JL, Lapeyre-Mestre M.
    Br J Clin Pharmacol; 2006 Aug 04; 62(2):225-31. PubMed ID: 16842398
    [Abstract] [Full Text] [Related]

  • 50. Paediatric adverse drug reaction reporting: understanding and future directions.
    Carleton BC, Smith MA, Gelin MN, Heathcote SC.
    Can J Clin Pharmacol; 2007 Aug 04; 14(1):e45-57. PubMed ID: 17297195
    [Abstract] [Full Text] [Related]

  • 51. Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region.
    Irujo M, Beitia G, Bes-Rastrollo M, Figueiras A, Hernández-Díaz S, Lasheras B.
    Drug Saf; 2007 Aug 04; 30(11):1073-82. PubMed ID: 17973543
    [Abstract] [Full Text] [Related]

  • 52. Parental reporting of suspected adverse drug reactions in children in Lagos, Nigeria.
    Oshikoya KA, Senbanjo IO, Njokanma OF.
    Arch Dis Child; 2009 Jun 04; 94(6):469-73. PubMed ID: 19147621
    [Abstract] [Full Text] [Related]

  • 53. Monitoring drug safety in Astrakhan, Russia.
    Kirilochev OO, Dorfman IP, Umerova AR.
    Int J Risk Saf Med; 2015 Jun 04; 27 Suppl 1():S33-4. PubMed ID: 26639700
    [Abstract] [Full Text] [Related]

  • 54. Community Pharmacists' Views and Experiences with ADR Reporting for Complementary Medicines: A Qualitative Study in New Zealand.
    Barnes J, Butler R.
    Drug Saf; 2020 Nov 04; 43(11):1157-1170. PubMed ID: 32975740
    [Abstract] [Full Text] [Related]

  • 55. Short communication: pattern of adverse drug reaction related queries received by the drug information centre of a tertiary care teaching hospital.
    Jimmy B, Jose J, Rao PG.
    Pak J Pharm Sci; 2007 Oct 04; 20(4):333-9. PubMed ID: 17604259
    [Abstract] [Full Text] [Related]

  • 56. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.
    Wysowski DK, Swartz L.
    Arch Intern Med; 2005 Jun 27; 165(12):1363-9. PubMed ID: 15983284
    [Abstract] [Full Text] [Related]

  • 57. Use and reported adverse effects of new chemical entities.
    Kennedy DL, Goetsch RA, Dreis MW.
    Am J Hosp Pharm; 1989 Mar 27; 46(3):558-65. PubMed ID: 2719041
    [Abstract] [Full Text] [Related]

  • 58. Dissemination of information on potentially fatal adverse drug reactions for cancer drugs from 2000 to 2002: first results from the research on adverse drug events and reports project.
    Ladewski LA, Belknap SM, Nebeker JR, Sartor O, Lyons EA, Kuzel TC, Tallman MS, Raisch DW, Auerbach AR, Schumock GT, Kwaan HC, Bennett CL.
    J Clin Oncol; 2003 Oct 15; 21(20):3859-66. PubMed ID: 14551305
    [Abstract] [Full Text] [Related]

  • 59. Hospital pharmacy compliance with JCAHO standards and ASHP guidelines for reporting adverse drug reactions.
    Tyler LS, Nickman NA.
    Am J Hosp Pharm; 1992 Apr 15; 49(4):845-50. PubMed ID: 1595720
    [Abstract] [Full Text] [Related]

  • 60. Characteristics associated with ability to prevent adverse drug reactions in hospitalized patients.
    Seeger JD, Kong SX, Schumock GT.
    Pharmacotherapy; 1998 Apr 15; 18(6):1284-9. PubMed ID: 9855328
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.